Trends in Feminizing Hormone Therapy for Transgender Patients, 2006-2017.
aldosterone antagonists
drug therapy
hormones
transgender persons
Journal
Transgender health
ISSN: 2688-4887
Titre abrégé: Transgend Health
Pays: United States
ID NLM: 101691357
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
pmc-release:
31
03
2024
medline:
5
4
2023
entrez:
4
4
2023
pubmed:
5
4
2023
Statut:
epublish
Résumé
Combination therapy with estrogen and spironolactone may help some transgender women achieve desired results. We used two databases, OptumLabs
Identifiants
pubmed: 37013092
doi: 10.1089/trgh.2021.0041
pii: 10.1089/trgh.2021.0041
pmc: PMC10066771
doi:
Types de publication
Journal Article
Langues
eng
Pagination
188-194Subventions
Organisme : NIMHD NIH HHS
ID : L60 MD012898
Pays : United States
Organisme : NIMHD NIH HHS
ID : R21 MD012371
Pays : United States
Informations de copyright
Copyright 2023, Mary Ann Liebert, Inc., publishers.
Déclaration de conflit d'intérêts
No competing financial interests exist.
Références
Am J Epidemiol. 2021 Sep 1;190(9):1928-1934
pubmed: 34467408
J Am Med Inform Assoc. 2018 Jul 1;25(7):905-908
pubmed: 29635362
Psychol Med. 2018 Oct;48(14):2329-2336
pubmed: 29331161
LGBT Health. 2016 Apr;3(2):100-2
pubmed: 26698386
N Engl J Med. 2019 Dec 19;381(25):2451-2460
pubmed: 31851801
Med Care. 2020 Oct;58(10):903-911
pubmed: 32925416
Arch Intern Med. 2000 Nov 27;160(21):3252-7
pubmed: 11088086
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903
pubmed: 28945902
Arch Sex Behav. 1989 Feb;18(1):49-57
pubmed: 2540730
JAMA. 1999 Oct 20;282(15):1458-65
pubmed: 10535437
LGBT Health. 2016 Jun;3(3):177-9
pubmed: 27135527